ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.
ABVC Biopharma has raised $1.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2023.
ABVC Biopharma is headquartered in Fremont, United States.
ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.
ABVC Biopharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ABVC Biopharma — Funding & Investors." VCBacked, July 27, 2023, https://www.vcbacked.co/company/abvc-biopharma. Accessed August 13, 2026.
VCBacked. (2023). ABVC Biopharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/abvc-biopharma
{{cite web |title=ABVC Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/abvc-biopharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated